-
A health system in Michigan treated a pregnant patient from Texas. She traveled to Michigan to end her pregnancy when doctors in Texas turned her away despite their acknowledgement that her fetus had a lethal fetal anomaly and would never live.
-
Five Supreme Court justices signaled in the Dobbs v. Jackson Women’s Health Organization oral arguments they were ready to overturn the 1973 Roe v. Wade decision, despite nearly five decades of precedent upholding abortion care as a constitutional right.
-
When adolescent females present at EDs with abdominal pain, they are inconsistently diagnosed through a gynecological history and pelvic exam. Sometimes, this can lead to the wrong treatment, which suggests a need for comprehensive sexual and gynecological health intake, according to researchers.
-
Although trichomoniasis likely is the most common nonviral STI in the world, and is potentially dangerous for birth outcomes, it is largely overlooked in screening and diagnosis. The CDC recently updated its STI treatment guidelines, recommending women with trichomoniasis receive multidose metronidazole 500 mg twice daily for seven days.
-
In March, the federal government sent Title X health providers a budget that will result in further slashes to programs that screen, test, trace, and treat people with STIs. STI rates are rising sharply for the sixth year in a row.
-
Contraceptive Technology Update asked Patricia A. Lohr, MD, MPH, medical director and director of the Centre for Reproductive Research & Communication at the British Pregnancy Advisory Service in the United Kingdom to explain how her new study’s findings suggest the usefulness of the low-sensitivity urine pregnancy test for use after a self-managed medication abortion.
-
Teen mothers need tangible support to help them with their contraceptive decisions and to prevent unintended rapid-repeat births, according to recent research. The AIM 4 Teen Moms program is a future-oriented behavioral intervention that can help influence teen mothers’ attitudes, intentions, and contraceptive use and behaviors.
-
The FDA should change the labeling for levonorgestrel-based emergency contraception to reflect evidence-based knowledge that the drug does not act as an abortifacient, according to researchers. The label change is especially important now, as states are banning abortions and sometimes defining it in ways that would prohibit pharmacies from selling emergency contraception under its current FDA labeling.
-
Medicaid expansion and other policies can make postpartum LARC more affordable. States also can create ways to make LARC affordable through programs in which hospitals can bill separately for intrauterine devices and their insertion.
-
LARC offers many safety and efficacy benefits. But there remain barriers in cost and the need for in-person clinic visits. The results of recent research show that as the cost is decreased, the percentage of women using IUDs increased.
